Science
Mechanism of Action
As an autophagy-inducing peptide, PENTASODIUM TETRACARBOXYMETHYL ACETYLHYDROXYPROLYL DIPEPTIDE-12 (PTPD-12) stimulates autophagic flux within skin cells. This process facilitates the degradation of melanosomes in both melanocytes and keratinocytes, leading to a measurable reduction in melanin content. It also effectively inhibits the uptake of melanosomes by keratinocytes. For sensitive skin, PTPD-12's autophagy-activating properties result in enhanced skin barrier function and diminished inflammatory responses, signaling endogenous cellular repair mechanisms.
Research
Clinical Evidence
Medium confidence2%
Key findings
- 01 An 8-week, randomized, split-face clinical trial involving 21 participants demonstrated that a cream formulated with 2% PTPD-12, applied twice daily, significantly reduced melanin levels in facial hyperpigmentation. The ingredient proved safe and well-tolerated, with no significant skin irritation reported.
- 02 A 4-week clinical trial illustrated that topical application of PTPD-12 improved sensitive skin conditions through its capacity to strengthen the skin barrier and exert anti-inflammatory effects.
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
While formal safety assessments from CIR, SCCS, or FDA are currently unavailable, clinical trials have consistently indicated no significant adverse effects or skin irritation at up to 2% concentration. External databases like SkinSAFE classify it as 'Irritant Free' and free of common allergens, with INCI Beauty reporting 'No penalty' across all categories.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This versatile autophagy-inducing peptide delivers significant efficacy in reducing hyperpigmentation and enhancing sensitive skin barrier function, positioning it as a valuable asset for advanced skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…